Accordingly, in our study, a stronger decrease of these metabolites in DEN-treated Aldh1l1 KO versus DEN-treated WT mice is in agreement with the tumor-promoting effect of the Aldh1l1 loss. Here, ALDH1L1 is linked to neoplasm.